Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 28, 2021 at 12:59 pm
Share
Baotou Dongbao Bio-Tech Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 412.27 million compared to CNY 301.07 million a year ago. Revenue was CNY 412.27 million compared to CNY 301.07 million a year ago. Net income was CNY 13.74 million compared to CNY 10.55 million a year ago. Basic earnings per share from continuing operations was CNY 0.0248 compared to CNY 0.0201 a year ago. Diluted earnings per share from continuing operations was CNY 0.0248 compared to CNY 0.0201 a year ago.
Baotou Dongbao Bio-Tech Co., Ltd is principally engaged in the research, development, manufacture and distribution of gelatin series products and low molecular mass collagen. The Company primarily provides gelatin, which is used in the manufacture of empty capsules and food additives; calcium hydrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, health care products. The Company distributes its products in both domestic and overseas markets, with domestic markets as its major markets.
BAOTOU DONGBAO BIO-TECH CO.,LTD 
